However, the cytokine TGF-β1 is not only linked to worse pulmonary outcomes in CF (7, 8), but can also diminish the efficacy of first/second generation modulators to rescue mutant CFTR function in vitro (9) by reducing the expression of CFTR mRNA (9–11). The gene discussed is CFTR; the disease is cystic fibrosis.